Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NVAX Novavax, Inc. daily Stock Chart
NVAX [NASD]
Novavax, Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-9.39 Insider Own0.30% Shs Outstand20.20M Perf Week-20.47%
Market Cap125.95M Forward P/E- EPS next Y-4.23 Insider Trans143.56% Shs Float- Perf Month42.35%
Income-181.60M PEG- EPS next Q-1.23 Inst Own30.70% Short Float- Perf Quarter1.88%
Sales28.60M P/S4.40 EPS this Y20.40% Inst Trans2.43% Short Ratio6.02 Perf Half Y-84.57%
Book/sh-6.42 P/B- EPS next Y33.10% ROA- Target Price21.64 Perf Year-76.91%
Cash/sh3.56 P/C1.75 EPS next 5Y0.00% ROE- 52W Range4.01 - 51.60 Perf YTD-83.06%
Dividend- P/FCF- EPS past 5Y-10.30% ROI- 52W High-87.92% Beta1.73
Dividend %- Quick Ratio2.70 Sales past 5Y10.40% Gross Margin- 52W Low55.49% ATR0.62
Employees379 Current Ratio2.70 Sales Q/Q-68.50% Oper. Margin- RSI (14)56.63 Volatility11.00% 11.72%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.69 Prev Close6.63
ShortableNo LT Debt/Eq- EarningsAug 07 AMC Payout- Avg Volume883.04K Price6.24
Recom2.10 SMA2019.40% SMA5021.05% SMA200-69.59% Volume609,993 Change-5.96%
Aug-14-19Reiterated H.C. Wainwright Buy $10 → $17
Feb-28-19Downgrade Piper Jaffray Overweight → Underweight $4.50 → $0.25
Dec-18-18Initiated Ladenburg Thalmann Buy $3
Dec-11-18Initiated Oppenheimer Outperform $4
Nov-26-18Upgrade Piper Jaffray Neutral → Overweight
Sep-21-18Upgrade JP Morgan Underweight → Overweight
Mar-29-18Upgrade Seaport Global Securities Neutral → Buy $5
Mar-19-18Downgrade JP Morgan Neutral → Underweight
Mar-01-18Upgrade Citigroup Neutral → Buy
Jan-05-18Initiated B. Riley FBR, Inc. Buy $2.25
Dec-19-17Downgrade Citigroup Buy → Neutral
Oct-31-17Upgrade Citigroup Neutral → Buy
Aug-09-17Upgrade Ladenburg Thalmann Neutral → Buy
Sep-20-16Reiterated Chardan Capital Markets Neutral $5.75 → $1.50
Sep-16-16Reiterated FBR & Co. Outperform $17 → $12
Sep-16-16Downgrade Wedbush Outperform → Neutral $14 → $2
Sep-16-16Downgrade Piper Jaffray Overweight → Neutral
Sep-16-16Downgrade Ladenburg Thalmann Buy → Neutral
Sep-16-16Downgrade JP Morgan Overweight → Neutral
Sep-16-16Downgrade Citigroup Buy → Neutral
Aug-23-19 08:35AM  4 Stocks That Boast Superb Earnings Acceleration Zacks -5.96%
Aug-21-19 09:39AM  Novavax, Inc. (NVAX) Shares March Higher, Can It Continue? Zacks
Aug-20-19 02:01PM  Need lab space? This Rockville research group is taking proposals. American City Business Journals -8.50%
Aug-19-19 06:00AM  Investors Who Bought Novavax (NASDAQ:NVAX) Shares Three Years Ago Are Now Down 94% Simply Wall St. -7.02%
Aug-18-19 07:37AM  3 Healthcare Stocks to Fight Off the Market Flu TipRanks
Aug-16-19 11:32AM  Why Novavax Stock Is Soaring Today Motley Fool +18.43%
Aug-15-19 09:30AM  4 Strong Buy Stocks to Follow Amid Recession Fears TipRanks +9.60%
Aug-14-19 01:03PM  Implied Volatility Surging for Novavax (NVAX) Stock Options Zacks +40.47%
01:00PM  Options Traders Take Chance on NVAX Stock After Big Analyst Call Schaeffer's Investment Research
Aug-13-19 02:19PM  New RSV vaccine data could boost Novavax as it searches for pathway to market American City Business Journals +6.97%
07:25AM  The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results Benzinga
Aug-12-19 07:00AM  New Data from Novavax Phase 3 Prepare Trial of ResVax Presented at 2019 IDSOG Annual Meeting GlobeNewswire
Aug-11-19 06:50PM  Edited Transcript of NVAX earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-19 09:58AM  Novavax Inc (NVAX) Q2 2019 Earnings Call Transcript Motley Fool -5.03%
Aug-08-19 07:00AM  Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting GlobeNewswire -5.41%
Aug-07-19 08:25PM  Novavax (NVAX) Reports Q2 Loss, Misses Revenue Estimates Zacks
06:32PM  Novavax looks to next flu vaccine trial following sale of manufacturing business American City Business Journals
04:05PM  Novavax Reports Second Quarter 2019 Financial Results GlobeNewswire
11:27AM  Germantown biopharma regains compliance with Nasdaq American City Business Journals
Aug-06-19 07:22AM  The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering Benzinga +9.43%
Aug-05-19 04:05PM  Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu GlobeNewswire
Aug-01-19 09:25AM  Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019 GlobeNewswire +5.34%
Jul-31-19 04:30PM  Novavax and Catalent Announce Closing of Strategic Partnership GlobeNewswire
Jul-09-19 01:39PM  Germantown stem cell therapy company proposes $7M offering amid delisting threat American City Business Journals
Jul-03-19 01:34PM  What Kind Of Shareholders Own Novavax, Inc. (NASDAQ:NVAX)? Simply Wall St. -10.41%
Jun-28-19 07:55PM  Heres What Hedge Funds Think About Novavax, Inc. (NVAX) Insider Monkey
10:10AM  Novavax (NVAX) Seeks Accelerated Approval Pathway for NanoFlu Zacks
Jun-27-19 10:51AM  Novavax Takes Accelerated Approval Pathway For Flu Vaccine Development Benzinga +11.19%
07:36AM  Will Novavax Continue to Surge Higher? Zacks
07:00AM  Novavax selling manufacturing business amid good news for flu vaccine American City Business Journals
07:00AM  Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu GlobeNewswire
06:59AM  Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax Manufacturing Assets and Capabilities GlobeNewswire
Jun-13-19 10:19AM  Novavax Enters Oversold Territory Zacks +5.48%
Jun-11-19 06:18PM  Novavax' Shares Drop as FDA Advises Another Study for Resvax Zacks -5.03%
07:34AM  The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering Benzinga
Jun-10-19 06:59AM  Novavax still plans to push RSV vaccine to market after failed trial American City Business Journals -12.25%
06:59AM  Novavax Provides Updates on the Global Pathways to Licensure for ResVax GlobeNewswire
Jun-04-19 04:05PM  Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention GlobeNewswire +5.52%
May-16-19 11:00AM  Are These 2 Beaten-Down Biotech Stocks Worth the Risk? Motley Fool
May-10-19 04:05PM  Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023 GlobeNewswire -8.62%
01:51AM  Edited Transcript of NVAX earnings conference call or presentation 2-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-09-19 02:44PM  How Novavax plans to advance after failed drug trial, delisting threat American City Business Journals -10.30%
May-08-19 04:05PM  Novavax Announces Reverse Stock Split of Common Stock GlobeNewswire
May-07-19 01:10PM  Why Novavax Stock Is Fading Today Motley Fool -12.51%
May-05-19 08:13PM  Heres What Hedge Funds Think About Novavax, Inc. (NVAX) Insider Monkey
May-03-19 09:00AM  Is Novavax a Buy? Motley Fool -10.28%
May-02-19 11:45PM  Novavax Inc (NVAX) Q1 2019 Earnings Call Transcript Motley Fool
07:25PM  Novavax (NVAX) Reports Q1 Loss, Misses Revenue Estimates Zacks
06:22PM  Novavax: 1Q Earnings Snapshot Associated Press
08:52AM  Is the Options Market Predicting a Spike in Novavax (NVAX) Stock? Zacks
May-01-19 04:05PM  Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization Program at 37th Annual Meeting of the European Society for Pediatric Infectious Diseases GlobeNewswire
09:28AM  What's in the Cards for Novavax (NVAX) This Earnings Season? Zacks
Apr-25-19 04:05PM  Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 2019 GlobeNewswire
09:39AM  Zacks Value Trader Highlights: Novavax, J.C. Penney, Pier 1 Imports, Tilray and Aurora Cannabis Zacks
Apr-24-19 11:19AM  Should You Buy Lottery Stocks? Zacks
Apr-16-19 08:10AM  The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives Benzinga
Apr-15-19 02:43PM  Novavax faces delisting threat following failed drug trial American City Business Journals
Apr-13-19 09:38AM  The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs Benzinga
Apr-12-19 09:20AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Novavax, Inc. ACCESSWIRE
Apr-11-19 05:45PM  Novavax (NVAX) Stock Moves -0.67%: What You Should Know Zacks
Apr-09-19 04:05PM  Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress GlobeNewswire
Apr-05-19 06:43PM  Edited Transcript of NVAX earnings conference call or presentation 18-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
05:45PM  Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know Zacks
Mar-27-19 05:45PM  Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
09:25AM  Four Healthcare Stocks Picking Up Speed on Wednesday ACCESSWIRE
Mar-22-19 02:06PM  3 Cheap Stocks to Buy That Are Worth Every Penny InvestorPlace -13.44%
08:46AM  Do Options Traders Know Something About Novavax (NVAX) Stock We Don't? Zacks
Mar-20-19 11:51AM  Why Novavax Is Soaring Today Motley Fool +16.38%
09:12AM  Does Novavax Have a Viable Path Forward? Motley Fool
07:00AM  What's Next for Novavax? Motley Fool
Mar-19-19 01:26AM  Novavax (NVAX) Q4 2018 Earnings Conference Call Transcript Motley Fool +5.91%
Mar-18-19 04:35PM  Novavax: 4Q Earnings Snapshot Associated Press
04:05PM  Novavax Reports Fourth Quarter and Year-End 2018 Financial Results GlobeNewswire
Mar-16-19 08:35AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Mar-13-19 03:00PM  These Four Healthcare Stocks Are Making Moves on Wednesday ACCESSWIRE
Mar-12-19 02:35PM  These Four Healthcare Stocks are Surging with Potential ACCESSWIRE
Mar-11-19 04:21PM  Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 18, 2019 GlobeNewswire
Mar-08-19 07:30AM  The Device Market That Drove One Company From $2.50 to $65 Has a New Entrant ACCESSWIRE -5.86%
Mar-07-19 08:51AM  Is a Beat in Store for Catabasis (CATB) This Earnings Season? Zacks
Mar-06-19 09:52AM  Four Healthcare Stocks Seeing Gains On Wednesday ACCESSWIRE -5.09%
Mar-05-19 01:52PM  Why Novavax Stock Imploded in February Motley Fool -5.29%
Mar-04-19 11:34PM  What's in the Cards for Novavax (NVAX) This Earnings Season? Zacks -10.18%
03:11PM  What another failed drug trial means for Novavaxs future American City Business Journals
08:46AM  Take a Poker Player's Approach to Playing Small Biotech Stocks TheStreet.com
Mar-03-19 07:09PM  The 3 Oldest Members of Biotech's Billion-Burned Club Motley Fool
Mar-01-19 08:50AM  The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis Benzinga
08:07AM  Can Novavax Convince the FDA Its Vaccine Deserves a Chance? Motley Fool
Feb-28-19 04:32PM  Why HP, Booking Holdings, and Novavax Slumped Today Motley Fool -66.90%
12:00PM  Novavax News: Why NVAX Stock Is Plunging Today InvestorPlace
11:06AM  Novavax Re-Enters Penny Stock Territory After Respiratory Disease Vaccine Flunks Late-Stage Trial Benzinga
10:39AM  Novavax Stock Is a Cautionary Tale for Speculators InvestorPlace
10:00AM  Why Novavax Stock Is Getting Crushed Today Motley Fool
07:43AM  Novavax shares crater 69% premarket after trial of ResVax misses its main goal MarketWatch
07:27AM  Novavax respiratory infection vaccine fails in late-stage trial Reuters
07:11AM  Novavax's respiratory infection vaccine fails in late-stage trial Reuters
07:00AM  Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax for Prevention of RSV Disease in Infants via Maternal Immunization GlobeNewswire
Feb-15-19 07:20AM  Research Report Identifies Novavax, Zillow Group, Broadridge Financial Solutions, Summit Midstream Partners, LP, Primoris Services, and RE/MAX with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-12-19 05:50PM  Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know Zacks
Feb-06-19 05:50PM  Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
Jan-28-19 02:09PM  Analyst: This Medical Stock Could Triple Schaeffer's Investment Research
Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company's lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein recombinant nanoparticle vaccine with aluminum phosphate as an adjuvant that is in Phase III clinical trial to protect infants from RSV disease through maternal immunization; and NanoFlu, which is in Phase II clinical trial for treating seasonal influenza in older adults. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, and the immune systems attack against microorganisms, as well as allows immunization with much lower doses of antigen. The company also develops RSV F vaccine for older adults in Phase II clinical trial, and healthy children between two and six years of age in Phase I clinical trial. In addition, it develops nanoparticle vaccine candidates for clinic testing against ebola virus in Phase I clinical trial, as well as MERS coronavirus in animals; and combination respiratory vaccine to protect against influenza and RSV. The company has a clinical development agreement with Bill & Melinda Gates Foundation. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Glenn Gregory MPresident, R&DMay 13Buy5.851,0005,85074,386May 13 05:19 PM
King Rachel K.DirectorMar 27Buy0.5344,00023,31122,000Mar 28 04:21 PM
King Rachel K.DirectorMar 27Buy0.5342,00022,25242,000Mar 28 04:21 PM
open in yahoo | open in reuters | open in google